nodes	percent_of_prediction	percent_of_DWPC	metapath
Nonoxynol-9—PTGS2—malignant glioma	0.978	1	CbGaD
Nonoxynol-9—PTGS2—S1P1 pathway—SPHK1—malignant glioma	0.00116	0.053	CbGpPWpGaD
Nonoxynol-9—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—malignant glioma	0.0011	0.0502	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—YEATS4—malignant glioma	0.000978	0.0446	CbGpPWpGaD
Nonoxynol-9—PTGS2—Overview of nanoparticle effects—PTGS1—malignant glioma	0.000864	0.0393	CbGpPWpGaD
Nonoxynol-9—PTGS2—Eicosanoid Synthesis—PTGS1—malignant glioma	0.000717	0.0326	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—ROS1—malignant glioma	0.000664	0.0303	CbGpPWpGaD
Nonoxynol-9—PTGS2—Overview of nanoparticle effects—PTK2—malignant glioma	0.000601	0.0274	CbGpPWpGaD
Nonoxynol-9—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—malignant glioma	0.0006	0.0273	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.000562	0.0256	CbGpPWpGaD
Nonoxynol-9—PTGS2—S1P1 pathway—PDGFB—malignant glioma	0.000505	0.023	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—PIM1—malignant glioma	0.000501	0.0228	CbGpPWpGaD
Nonoxynol-9—PTGS2—S1P1 pathway—KDR—malignant glioma	0.000473	0.0216	CbGpPWpGaD
Nonoxynol-9—PTGS2—Overview of nanoparticle effects—FN1—malignant glioma	0.000456	0.0208	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—BCAN—malignant glioma	0.000403	0.0183	CbGpPWpGaD
Nonoxynol-9—PTGS2—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000398	0.0181	CbGpPWpGaD
Nonoxynol-9—PTGS2—Overview of nanoparticle effects—PIK3CD—malignant glioma	0.000383	0.0175	CbGpPWpGaD
Nonoxynol-9—PTGS2—Overview of nanoparticle effects—BCL2—malignant glioma	0.000349	0.0159	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—MYB—malignant glioma	0.000334	0.0152	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—GDNF—malignant glioma	0.000325	0.0148	CbGpPWpGaD
Nonoxynol-9—PTGS2—Overview of nanoparticle effects—CXCL8—malignant glioma	0.000321	0.0146	CbGpPWpGaD
Nonoxynol-9—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—malignant glioma	0.000299	0.0136	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—GFAP—malignant glioma	0.000279	0.0127	CbGpPWpGaD
Nonoxynol-9—PTGS2—S1P1 pathway—VEGFA—malignant glioma	0.000261	0.0119	CbGpPWpGaD
Nonoxynol-9—PTGS2—Selenium Micronutrient Network—PTGS1—malignant glioma	0.000254	0.0115	CbGpPWpGaD
Nonoxynol-9—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malignant glioma	0.000246	0.0112	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—LGALS3—malignant glioma	0.000244	0.0111	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000233	0.0106	CbGpPWpGaD
Nonoxynol-9—PTGS2—Overview of nanoparticle effects—TNF—malignant glioma	0.000224	0.0102	CbGpPWpGaD
Nonoxynol-9—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malignant glioma	0.000219	0.00997	CbGpPWpGaD
Nonoxynol-9—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—malignant glioma	0.000194	0.00884	CbGpPWpGaD
Nonoxynol-9—PTGS2—Selenium Micronutrient Network—SOD1—malignant glioma	0.000192	0.00875	CbGpPWpGaD
Nonoxynol-9—PTGS2—Selenium Micronutrient Network—CAT—malignant glioma	0.000182	0.00831	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—HES1—malignant glioma	0.00018	0.00819	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—NCOR1—malignant glioma	0.000179	0.00814	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000176	0.00804	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000169	0.00768	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000167	0.00762	CbGpPWpGaD
Nonoxynol-9—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malignant glioma	0.000159	0.00725	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—GJA1—malignant glioma	0.000157	0.00716	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000149	0.00679	CbGpPWpGaD
Nonoxynol-9—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—malignant glioma	0.000148	0.00674	CbGpPWpGaD
Nonoxynol-9—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—malignant glioma	0.000142	0.00645	CbGpPWpGaD
Nonoxynol-9—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malignant glioma	0.000142	0.00645	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000136	0.00621	CbGpPWpGaD
Nonoxynol-9—PTGS2—Selenium Micronutrient Network—F2—malignant glioma	0.000134	0.00609	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000129	0.00586	CbGpPWpGaD
Nonoxynol-9—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—malignant glioma	0.000121	0.00551	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000118	0.00539	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.000116	0.00527	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—RTEL1—malignant glioma	0.000111	0.00505	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.00011	0.00502	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.000109	0.00498	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—CDKN2A—malignant glioma	0.000108	0.00491	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—BCL2—malignant glioma	0.000106	0.00483	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000106	0.00483	CbGpPWpGaD
Nonoxynol-9—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malignant glioma	0.000103	0.00469	CbGpPWpGaD
Nonoxynol-9—PTGS2—Selenium Micronutrient Network—IFNG—malignant glioma	0.000101	0.00461	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	9.86e-05	0.00449	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	9.77e-05	0.00445	CbGpPWpGaD
Nonoxynol-9—PTGS2—Selenium Micronutrient Network—IL1B—malignant glioma	9.04e-05	0.00412	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	8.88e-05	0.00404	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—IFNG—malignant glioma	8.01e-05	0.00365	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	7.93e-05	0.00361	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.93e-05	0.00361	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.67e-05	0.00349	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—CXCL8—malignant glioma	7.45e-05	0.00339	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—MYC—malignant glioma	7.31e-05	0.00333	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—IL1B—malignant glioma	7.15e-05	0.00325	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—CASP3—malignant glioma	7.13e-05	0.00325	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—IL2—malignant glioma	7.12e-05	0.00324	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	7.11e-05	0.00324	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	6.88e-05	0.00313	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	6.8e-05	0.0031	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—KRAS—malignant glioma	6.75e-05	0.00307	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—MMP9—malignant glioma	6.74e-05	0.00307	CbGpPWpGaD
Nonoxynol-9—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	6.56e-05	0.00299	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—COX8A—malignant glioma	6.37e-05	0.0029	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—BCAN—malignant glioma	6.08e-05	0.00277	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	5.79e-05	0.00264	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.69e-05	0.00259	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—MYC—malignant glioma	5.57e-05	0.00254	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	5.5e-05	0.00251	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—DTX1—malignant glioma	5.5e-05	0.0025	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	5.45e-05	0.00248	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	5.42e-05	0.00247	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—ASMT—malignant glioma	5.42e-05	0.00247	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	5.4e-05	0.00246	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	5.34e-05	0.00243	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.29e-05	0.00241	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—TNF—malignant glioma	5.19e-05	0.00236	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—BCAN—malignant glioma	5.09e-05	0.00232	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	4.85e-05	0.00221	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—TP53—malignant glioma	4.57e-05	0.00208	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	4.56e-05	0.00208	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—HEY2—malignant glioma	4.32e-05	0.00197	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—IDH1—malignant glioma	4.22e-05	0.00192	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	4.12e-05	0.00187	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—IDH2—malignant glioma	4.11e-05	0.00187	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—HEY1—malignant glioma	4e-05	0.00182	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—HIST1H3B—malignant glioma	3.88e-05	0.00177	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.87e-05	0.00176	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—CYP2B6—malignant glioma	3.86e-05	0.00176	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.79e-05	0.00172	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.7e-05	0.00169	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—JAG2—malignant glioma	3.54e-05	0.00161	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—IDH1—malignant glioma	3.53e-05	0.00161	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.53e-05	0.00161	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.5e-05	0.00159	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—SPHK1—malignant glioma	3.42e-05	0.00156	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—CYP2C18—malignant glioma	3.35e-05	0.00152	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.22e-05	0.00146	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.16e-05	0.00144	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.11e-05	0.00142	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—H3F3A—malignant glioma	3e-05	0.00137	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.87e-05	0.00131	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—JAG1—malignant glioma	2.83e-05	0.00129	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.77e-05	0.00126	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—FBXW7—malignant glioma	2.77e-05	0.00126	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—GSTT1—malignant glioma	2.71e-05	0.00123	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.63e-05	0.0012	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—PTGS1—malignant glioma	2.54e-05	0.00115	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.53e-05	0.00115	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—BCHE—malignant glioma	2.36e-05	0.00107	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—SLC5A5—malignant glioma	2.33e-05	0.00106	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.2e-05	0.001	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—CDKN2B—malignant glioma	2.17e-05	0.000988	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—HES1—malignant glioma	2.07e-05	0.000943	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—NCOR1—malignant glioma	2.06e-05	0.000937	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—PDGFRA—malignant glioma	1.97e-05	0.000898	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.9e-05	0.000867	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—GSTP1—malignant glioma	1.88e-05	0.000854	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—CAT—malignant glioma	1.83e-05	0.000831	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—TERT—malignant glioma	1.81e-05	0.000826	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—HLA-A—malignant glioma	1.81e-05	0.000826	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—PDGFB—malignant glioma	1.77e-05	0.000806	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—FGFR1—malignant glioma	1.76e-05	0.000802	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—HIF1A—malignant glioma	1.74e-05	0.00079	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—NCOR1—malignant glioma	1.72e-05	0.000785	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—CAV1—malignant glioma	1.68e-05	0.000764	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—BAD—malignant glioma	1.58e-05	0.000719	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—NOTCH1—malignant glioma	1.56e-05	0.000712	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—CD80—malignant glioma	1.53e-05	0.000697	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—APC—malignant glioma	1.53e-05	0.000696	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—EGF—malignant glioma	1.51e-05	0.000688	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—PTPN11—malignant glioma	1.5e-05	0.000684	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—BRAF—malignant glioma	1.44e-05	0.000654	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—CAV1—malignant glioma	1.41e-05	0.00064	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—AKT2—malignant glioma	1.4e-05	0.000637	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—PIK3CD—malignant glioma	1.34e-05	0.000612	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.34e-05	0.000611	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—FGF2—malignant glioma	1.29e-05	0.000586	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—PIK3CG—malignant glioma	1.28e-05	0.000583	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—PPARG—malignant glioma	1.24e-05	0.000563	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—MDM2—malignant glioma	1.2e-05	0.000548	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—RAF1—malignant glioma	1.2e-05	0.000546	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—ERBB2—malignant glioma	1.19e-05	0.00054	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—PIK3CB—malignant glioma	1.17e-05	0.000533	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—PIK3CD—malignant glioma	1.13e-05	0.000512	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—PTEN—malignant glioma	1.01e-05	0.000461	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—PIK3CB—malignant glioma	9.81e-06	0.000447	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—STAT3—malignant glioma	9.05e-06	0.000412	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—PTEN—malignant glioma	8.48e-06	0.000386	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—MYC—malignant glioma	8.41e-06	0.000383	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—EGFR—malignant glioma	8.23e-06	0.000375	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—KRAS—malignant glioma	7.77e-06	0.000354	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—PIK3CA—malignant glioma	7.14e-06	0.000325	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—PIK3CA—malignant glioma	5.98e-06	0.000272	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—AKT1—malignant glioma	5.83e-06	0.000266	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—AKT1—malignant glioma	4.88e-06	0.000222	CbGpPWpGaD
